Secukinumab - efficacy and safety in Ankylosing Spondylitis extension

• Research type

  Research Study

• Full title

  An extension study to evaluate the sustainability of clinical benefits, safety and tolerability of secukinumab in patients with active Ankylosing Spondylitis

• IRAS ID

  137103

• Contact name

  Hasan Tahir

• Contact email

  hasan.tahir@bartshealth.nhs.uk

• Sponsor organisation

  Novartis Pharma Services AG

• Eudract number

  2013-001089-40

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  13/EM/0357

• Date of REC Opinion

  3 Oct 2013

• REC opinion

  Favourable Opinion